Ph.D., University of Washington, Epidemiology, 2010.
M.P.H., University of California, Berkeley, Epidemiology and Biostatistics, 2003.
B.A., Northwestern University, Molecular and Cell Biology, 2001.
Dr. Phipps’ research interests span the fields of cancer epidemiology, molecular epidemiology, and clinical epidemiology. In particular, her work is focused on identifying ways in which cancer survival differs according to aspects of a patient’s lifestyle (e.g., smoking, physical activity) and aspects of tumor biology (e.g., KRAS mutation status, microsatellite instability). Her current projects focus on the relationship between modifiable lifestyle behaviors and survival in individuals with biologically-distinct subtypes of colorectal cancer, and on the relationship between obstructive sleep apnea and cancer. She also works closely with the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) and other studies to help identify genetic factors and tumor attributes that contribute to colorectal cancer prognosis. In addition to her current work in colorectal cancer survival, she has an interest in molecular subtypes of breast cancer, particularly in risk factors for the poor-prognosis triple-negative subtype of breast cancer.
1. Phipps AI, Robinson JR, Campbell PT, Win AK, Figueiredo JC, Lindor NM, Newcomb PA. Prediagnostic alcohol consumption and colorectal cancer survival: The Colon Cancer Family Registry. Cancer. 2016 Nov 8. [Epub ahead of print] PMID: 27861761
2. Phipps AI, Bhatti P, Neuhouser ML, Chen C, Crane TE, Kroenke CH, Ochs-Balcom H, Rissling M, Snively BM, Stefanick ML, Treggiari MM, Watson NF. Pre-diagnostic Sleep Duration and Sleep Quality in Relation to Subsequent Cancer Survival. J Clin Sleep Med. 2016; 12(4):495-503. PMCID: PMC4795275
3. Phipps AI, Shi Q, Limburg PJ, Nelson GD, Sargent DJ, Sinicrope FA, Chan E, Gill S, Goldberg RM, Kahlenberg M, Nair S, Shields AF, Newcomb PA, Alberts SR; Alliance for Clinical Trials in Oncology. Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147. Int J Cancer. 2016; 139(5):986-95. PMCID: PMC4911257
4. Hardikar S, Newcomb PA, Campbell PT, Win AK, Lindor NM, Buchanan DD, Makar KW, Jenkins MA, Potter JD, Phipps AI. Prediagnostic Physical Activity and Colorectal Cancer Survival: Overall and Stratified by Tumor Characteristics. Cancer Epidemiol Biomarkers Prev. 2015; 24(7):1130-7. PMCID: PMC4491038
5. Phipps AI, Passarelli MN, Chan AT, Harrison TA, Jeon J, Hutter CM, Berndt SI, Brenner H, Caan BJ, Campbell PT, Chang-Claude J, Chanock SJ, Cheadle JP, Curtis KR, Duggan D, Fisher D, Fuchs CS, Gala M, Giovannucci EL, Hayes RB, Hoffmeister M, Hsu L, Jacobs EJ, Jansen L, Kaplan R, Kap EJ, Maughan TS, Potter JD, Schoen RE, Seminara D, Slattery ML, West H, White E, Peters U, Newcomb PA. Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis. Carcinogenesis. 2016; 37(1):87-95. PMCID: PMC4715234
6. Phipps AI, Limburg PJ, Baron JA, Burnett-Hartman AN, Weisenberger DJ, Laird PW, Sinicrope FA, Rosty C, Buchanan DD, Potter JD, Newcomb PA. Association between molecular subtypes of colorectal cancer and patient survival. Gastroenterology. 2015; 148(1):77-87.e2. PMCID: PMC4274235
7. Phipps AI, Chan AT, Ogino S. Anatomic subsite of primary colorectal cancer and subsequent risk and distribution of second cancers. Cancer. 2013; 119(17):3140-7. PMCID: PMC3775988